IL21 and type 1 diabetes mellitus: Interleukin-21 (IL-21), a cytokine produced by T cells, plays an important role in the trafficking and activation of autoreactive CD8+ T cells in the beta cell (72, 73), thus making it a potential therapy target in the prevention of T1D.